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Abstract
Background: Epidemiological studies have demonstrated adverse health effects of environmental
pollution. Diesel exhaust (DE) is a major contributor to particulate matter pollution. DE exposure
has been shown to induce a pronounced inflammatory response in the airways, together with an
enhanced epithelial expression of cytokines such as IL-8, Gro-α, IL-13 and activation of redox
sensitive transcription factors (NFκB, AP-1), and MAP kinases (p38, JNK). The aim of the present
investigation was to elucidate the involvement of the epidermal growth factor receptor (EGFR)
signalling pathway in the epithelial response to DE in-vivo.
Results: Immunohistochemical staining was used to quantify the expression of the EGFR,
phosphorylated Tyrosine residues, MEK and ERK in the bronchial epithelium of archived biopsies
from 15 healthy subjects following exposure to DE (PM10, 300 µg/m3) and air. DE induced a
significant increases in the expression of EGFR (p = 0.004) and phosphorylated C-terminal Tyr 1173
(p = 0.02). Other investigated EGFR tyrosine residues, Src related tyrosine (Tyr 416), MEK and
ERK pathway were not changed significantly by DE.
Conclusion: Exposure to DE (PM10, 300 µg/m3) caused enhanced EGFR expression and
phosphorylation of the tyrosine residue (Tyr 1173) which is in accordance with the previously
demonstrated activation of the JNK, AP-1, p38 MAPK and NFkB pathways and associated
downstream signalling and cytokine production. No effects were seen on the MEK and ERK
pathway suggesting that at the investigated time point (6 hours post exposure) there was no
proliferative/differentiation signalling in the bronchial epithelium. The present findings suggest a key
role for EGFR in the bronchial response to diesel exhaust.
Introduction
Numerous studies have reported an association between
increased ambient levels of particulate matter (PM) pollu-
tion and increased respiratory and cardiovascular morbid-
ity as well as mortality [1,2]. Diesel engine exhaust (DE)
is a major contributor to ambient PM pollution and diesel
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particles (nanoparticles) compared to gasoline engines.
Diesel exhaust particles (DEP) have been shown to have
substantial toxicological capacity, associated with particle
size and surface chemistry characteristics, including metal
and organic components with oxidative capability [3-6].
Mechanistic aspects of DE exposure in humans have been
addressed in a series of experimental studies [7-12].
Changes in the production of IL-8, IL-10, IL-13 and Gro-
α in the bronchial epithelium as well as an upregulation
in the expression of the vascular endothelial adhesion
molecules ICAM-1 and VCAM-1 have been demonstrated.
These findings were accompanied by a pronounced
inflammatory cell infiltration, including activated neu-
trophils, lymphocytes and mast cells in the bronchial
mucosa [7,9-12] as well as generation of reactive oxygen
species (ROS) and signs of oxidative stress [8]. Of note,
asthmatic subjects have an enhanced sensitivity to PM air
pollution [1,13] while having an compromised oxidative
defence capacity. Asthmatics also have a different inflam-
matory response to DE than healthy subjects and develop
increased bronchial hyperresponsiveness following chal-
lenge [12,14].
Bronchial mucosal biopsies, sampled after air and DE
exposures in healthy humans, have been instrumental in
determining the epithelial expression of redox sensitive
mitogen-activated protein kinases (MAPKs) and transcrip-
tion factors involved in the regulation of airway inflam-
mation. Using this approach it was demonstrated that DE
activates the p38 and JNK MAPK pathways and leads to
increased expression of the NFκB and AP-1 transcription
factors, associated with findings of downstream cytokine
production [9,11,15]. Receptor tyrosine kinases (RTKs),
including epidermal growth factor receptor (EGFR), are
primary mediators of external stimuli and incoming sig-
nals. EGFR has been demonstrated to play a key role in
bronchial epithelial repair, remodelling and control of
airway inflammation. It achieves this by regulating a range
of cellular processes including mitogenesis, apoptosis,
migration, differentiation and proliferation, all of which
are of important in many situations and conditions,
including asthma. Furthermore, EGFR activation by met-
als and hydrocarbons with oxidative capacity has been
shown to activate downstream MAPkinases and transcrip-
tion factors [16-18].
In the present study, we therefore sought to investigate the
hypothesis that the activation of transcription factors and
MAP kinases and increased downstream production of
cytokines observed in bronchial mucosal biopsies follow-
ing DE challenge in human subjects was accompanied by
activation of upstream pathways such as EGFR and phos-
phorylation or transphosphorylation of specific tyrosine
residues of EGFR such as Tyr 845, Tyr 992, Tyr 1068, Tyr
1110 and Tyr 1173. In addition, we investigated whether
EGFR activation by diesel exposure could be mediated by
Src activation and phosphorylation of Src Tyr 416 and
leading to transactivation of EGFR at Tyr 845 and whether
activation of EGFR would increase the downstream MEK-
ERK pathway signalling, linked to proliferation and differ-
entiation.
Results
The immunoreactivity for EGFR was evident on the baso-
lateral border of the columnar cell (figure 1A) when sub-
jects were exposed to air. Following exposure to DE,
expression could be observed throughout the epithelial
layer (figure 1B). Immunostaining of phosphorylated Tyr
1173 was intracytoplasmatic in the baso-perinuclear
region of the columnar cells and on the basolateral bor-
ders of the basal cells in the bronchial epithelium after
exposure to both air and DE (figure 1C and 1D respec-
tively).
Short term exposure to diesel exhaust induced a signifi-
cant increase in the expression of EGFR in the bronchial
epithelium; 0.69% (median) of the total epithelial area
compared to 0.24% after air exposure (p = 0.004). This
change was accompanied by an increased phosphoryla-
tion of Tyr 1173; 3.2% after diesel exhaust exposure vs.
2.2% after air (p = 0.02). The expression of other EGFR
tyrosine residues such as Tyr 845, Tyr 992, Tyr 1068 and
Tyr 1110 and Src related tyrosine (Tyr416) and the ERK
pathway (MEK and ERK) were not significantly altered
after diesel exposure (Table 1)
Discussion
Diesel engine exhaust has been demonstrated to induce
inflammation in the bronchial epithelium, which apart
from its classical barrier function, increasingly has been
demonstrated to carry important immune regulatory
properties. The EGFR has been shown to be of importance
in these principal functions, as highlighted in respiratory
diseases such as asthma, the most common condition rec-
ognised to be affected by particulate air pollution [19-22].
In this first in vivo study examining the involvement of
EGFR in the human airways responses to DE, analyses of
bronchial mucosal biopsies demonstrated a significantly
increased expression of EGFR in the bronchial epithelium
six hours after challenge. This was associated with a signif-
icantly increased phosphorylation of the Tyr 1173 auto-
phosphorylation site on the EGFR C-terminal. Src was not
found to be involved in the EGFR activation as indicated
by unchanged phosphorylation of Src Tyr 416 and EGFR
Tyr 845. At this time post DE exposure, the EGFR down-
stream MEK/ERK signalling pathway was also unaffected.Page 2 of 9
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ImmunostainingFigure 1
Immunostaining. Immunoreactivity within the bronchial epithelium for EGFR after air and diesel exhaust exposure. Positive 
staining (brown) can be seen on the basolateral border of the columnar cells after exposure to air (panel A) and throughout 
the epithelium following exposure to diesel exhaust (panel B). Arrows show intracytoplasmatic Tyr 1173 immunostaining in 
the basoperinuclear region of columnar cells and basolateral border of basal cells (panel C After air exposure and panel D 
after DE exposure). Panel E: Primary IgG antibody serving as a negative contol. Panel F demonstrates the normal brown 
DAB staining in panel D which is presented by red color following computer-aided selection and quantification by the image 
analyser program.
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regulate cytokine production and inflammatory responses
may be activated by MAPKs and their upstream signalling
pathways. This has been confirmed to take place in the
human airway epithelium after DE exposure, by analyses
of archived human bronchial biopsies [15]. The nuclear
expression of phosphorylated p38 MAPK was significantly
upregulated, together with increased nuclear transloca-
tion of p-JNK MAPK and c-jun of the AP-1 complex. Addi-
tionally, the nuclear expression of NFκB was increased.
These transcription factors are known to control the pro-
duction of a wide range of cytokines. DE exposure has
been shown to enhance the production of IL-8 and Gro-α
in the bronchial epithelium, accompanied by a pro-
nounced neutrophil influx in the bronchial wall. This
neutrophilia was mediated by the upregulation of the vas-
cular adhesion molecule expression of P-selectin and
ICAM-1 [10-12]. Furthermore, a DE mediated increase in
the bronchial epithelial expression of IL-13 has been
reported [9]. When considering upstream signalling and
regulation of these signal transduction pathways, it is clear
that EGFR could have the potential to regulate, or assist in
regulating, all the above mentioned events. Therefore a
critical question to address was whether activation of
EGFR would occur after inhalation of diesel exhaust,
which is a complex mixture of gases and particulates.
Most likely, nitrogen dioxide (NO2), a major gaseous
component in DE does not play any major role in the
bronchial mucosal effects of DE in humans [23]. In con-
trast to DE, exposure to NO2 at levels similar or higher
than employed here, has failed to elicit any bronchial
mucosal inflammatory responses [23]. Indeed, there are
several indications in the literature that metal and hydro-
carbon induced oxidative stress in the airways is involved
in the airway response to DE. Even though the metal con-
tent in DEP is usually not as extensive as in residual oil fly
ash (ROFA), it is clear that the content of transition metals
may contribute to oxidative stress [8].
Oxidative stress related to hydrocarbons has de facto been
suggested to be a common denominator for many DEP-
induced cellular effects. Reactive oxygen species (ROS)
can be produced following metabolism and bioactivation
of hydrocarbons by cytochrome P-450 1A1 (CYP1A1).
The polar quinones have the capacity to generate oxida-
tive stress by redox cycling. Additionally, the metabolism
of semiquinones by NADPH-cytrochrome P-450 reduct-
ase followed by autooxidation also results in ROS produc-
tion [24-26]. Development of oxidative stress in the
airways following DE challenge has been implied by anal-
yses of human airway lavage samples [8]. Furthermore,
genetic polymorphisms in Glutathione-S-transferases
(GSTs) have been indicated to be critical for the defence
against ROS and detoxification of DEP. The GSTM1 and
GSTP1 genotypes have been confirmed to modify the
allergen response by DEP in the nose in human subjects
[27]. There are several studies indicating that EGFR is acti-
vated by metals, organic components and oxidative stress,
supporting the notion that this receptor tyrosine kinase
may play a major regulatory role in the inflammatory
response to DE exposure [16,18,28]. While only provid-
ing indirect evidence, two recent studies have more specif-
ically investigated the role of EGFR after exposure to DEP
in-vitro [29,30]. In these studies, the authors were able to
demonstrate that DEP triggered the secretion of amphireg-
ulin, a ligand of EGFR, from bronchial epithelial cells,
which could be blocked by ERK and EGFR tyrosine kinase
inhibition as well as antioxidant supplementation. Fur-
thermore, DEP quinone compounds have been shown to
induce contraction of smooth muscle cells, mediated by
activated phospholipase A2. This signalling pathway
could be blocked by PTK and EGFR inhibitors. Taken
together, these studies demonstrate the ability of DEP to
both activate and transactivate EGFR.
EGFR has an extracellular ligand-binding domain, a mem-
brane-spanning domain and a cytoplasmatic protein tyro-
sine kinase domain with a carboxyl terminal that contains
Table 1: Immunoractivity of investigated antibodies in 15 Air and DE paired subjects participated in study.
Immunoreactivity Air Diesel p value
EGFR 0.240 (0.100–0.370) 0.690 (0.210–1.960) p = 0.004
Tyr 845 0.220 (0.027–0.520) 0.460 (0.160–1.030) p = 0.1
Tyr 992 0.450 (0.320–0.580) 0.530 (0.220–1.540) p = 0.14
Tyr 1068 0.015 (0.002–0.250) 0.180 (0.013–0.550) p = 0.18
Tyr 1110 1.090 (0.560–2.140) 1.780 (0.980–2.200) p = 0.39
Tyr 1173 2.230 (1.380–2.890) 3.160 (1.800–5.070) p = 0.02
Tyr 416 0.033 (0.001–0.120) 0.016 (0.003–0.800) p = 0.13
MEK 1, 2 1.330 (0.310–2.670) 1.410 (0.630–4.440) p = 0.28
ERK 1, 2 0.140 (0.024–0.320) 0.160 (0.045–0.650) p = 0.14
Two sections from each biopsy and exposure were evaluated during investigation of each antibody.
Bronchial epithelium expression of EGFR, Tyrosine sites and downstream signalling immunoreactivity is given as percentage (%) positively stained 
area of the total measured epithelial area. All values are quoted as medians with inter-quartile range. Statistical comparisons by Wilcoxon's paired 
rank test.Page 4 of 9
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ing receptor activation [31-34]. Three major tyrosine sites,
Y1068, Y1173 and Y1148 and two minor tyrosine sites,
Y992 and Y1086, serve as sites of autophosphorylation
following ligand binding or transphosphorylation by
other stimuli (figure 2). These autophosporylation sites
function as binding sites for Src homology 2 (SH2) and
protein tyrosine binding (PTB) domains of a variety of sig-
nalling proteins with enzyme activity such as phospholi-
pase C-γ (PLC-γ), signal transducers such as PI3-K and
adaptor proteins such as Growth factor receptor-binding
protein 2 (Grb2) and Src-homology and collagen protein
(Shc). These create binding sites for SH2 or protein tyro-
sine binding (PTB) domains of proteins or adaptor mole-
cules that link EGFR activation to the downstream
signalling pathway.
Description of possible involved signalling pathwaysFigu e 2
Description of possible involved signalling pathways. Schematically description of possible involved signalling pathways 
in the activation and phosphorylation of EGFR, protein tyrosine kinases and downstream signalling following DE exposure. 
Extended and modified from Puddicombe SM et al. Clinical and Experimental Allergy, 2000, 30, 7–11. The graph is inserted to 
allow for better understanding of the pathways and mediators discussed in this paper and is by no means conclusive. The yel-
low box shows the PTK activation pathway through cellular and oxidative stress, cytokine receptors and GPCR. N-SH2 
domian in PLC-gamma recognize Tyr 1173 and is primary contributor to PLC-gamma association with the EGFR. Moreover 
stimulation of various GPCRs such as lysophosphatic acid (LPA) and endothelin-1 (ET-1) rapidly induce phosphorylation of 
adaptor protein Shc and Shc – Grb2 complex formation. Tyr 1173 on EGFR can function as a docking site for PLC-gamma and 
PI3-K (green arrow from yellow box). Furthermore Tyr 1173 interact with both SH2 and PTB domains in adoptor protein Shc 
plays major role in the Ras signalling and subsequence the EGF mediated activation of JNK which is dependent on Shc and con-
trolling JNK activation and possible signalling pathways involved in MEKK1 activation and regulation of JNK and p38 MAPKs 
after EGF stimulation (red arrows show the signalling direction in the blue box).Page 5 of 9
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transforming growth factor-α (TGF-α) and amphiregulin
may cause downstream activation of the Ras/MAPK path-
way. Importantly, EGFR transduces not only its own lig-
ands, but also various stimuli, such as cytokines via
cytokine receptors and/or G-protein-coupled receptor
activation, as well as oxidative stress all of which result in
transactivation. The increased EGFR expression demon-
strated after DE in this study is expected to be related to a
ligand – activated receptor and inhibition of endocytosis
and degradation of receptor which leads to increased
receptor expression.
The observation of enhanced phosphorylation of Tyr
1173 is in accordance with the previously demonstrated
DE-induced increase in epithelial expression of NFkB,
JNK, c-jun and p38 MAPK together with cytokines under
their regulation such as IL-8 and GRO-α. Increased phos-
phorylated Tyr 1173 can function as a docking site for sig-
nalling systems such as PLC-γ or PI3-K (figure 2, yellow
box) and exert oxidative responses following DE expo-
sure, linking to NFkB as well as Ras activation [35,36]. Tyr
1173 is suggested to be the primary autophosphorylated
site that is involved in the PLC-γ association with EGFR
[37], and that signal transduction across membrane cou-
pled to PI3-Kinase may be involved in the activation of
PLC-γ [38]. The autophosphorylated Tyr1173 also acts as
a docking site for Shc (Src-homology and collagen pro-
tein) which in turn can bind to Grb2 (Growth factor
receptor-binding protein 2) and build Shc-Grb2-Sos com-
plex which leads to downstream activation [39,40].
The adaptor protein Shc binding to Grb2, complex build-
ing and subsequence MEK kinase-1 (MEKK1) activation
may specifically regulate the demonstrated JNK and p38
MAPK activation (figure 2 blue box). It has been suggested
that EGFR mediated JNK signalling is regulated by Shc and
a transient interaction of Grb2 and MEKK1 [39,41]. In
contrast, ERK pathway induction is depending on binding
of the Grb2-Sos complex to Tyr 1068 and mediated by
MEK1 phosphorylation, which was not increased in the
present material [42,43]. The ERK pathway was expected
to be upregulated in the present diesel challenge scenario,
as were the JNK and p38 MAPK pathways. ERK activation
transduces proliferative and differentiation responses
which could be in demand after diesel challenge. The
absence of ERK pathway activation contrasts with that
seen in a recent study by Blanchet et al, [29] who demon-
strated PM2.5 and archived DEP to cause specific ERK acti-
vation, with amphiregulin secretion, by use of different
blocking agents for the MAPK pathways. Amphiregulin is
an EGFR ligand known to contribute to GM-CSF release,
which can be important for sustaining a proinflammatory
response. Analyses of the present biopsy material not only
failed to show any DE-induced increase in ERK activation
but, as previously reported, GM-CSF expression was unal-
tered [11]. The difference between this study and that of
Blanchet et al, may be due to a dose threshold effect.
Another possibility is the time course of events, since in
the current study bronchial mucosal biopsies were sam-
pled at 6 hours after in-vivo DE exposure and Blanchet et
al determined the in-vitro response in the 16-HBE cells
after 18 hours and in absence of cooperation with other
signalling involved in an in-vivo system. The question
whether the ERK pathway is activated at a later time point
after in-vivo diesel exposure in humans in-vivo, will
shortly be addressed in archived biopsies sampled 18
hours post exposure [7]. Of even more importance, EGFR
pathway activation after DE exposure, can also be
addressed in archived biopsies from asthmatic subjects
[12], in which EGFR pathways are of major importance in
terms of epithelial barrier integrity, airway remodelling
and signal transduction [21,44].
To examine the potential role of metals in DE induced
EGFR activation, cellular PTK or non-receptor protein
tyrosine kinase such as Src were considered. Src can act as
co-transducer of EGFR signals and has been demonstrated
to be involved in the responses of Zn2+-induced Ras acti-
vation via the EGFR. Src-dependent EGFR signalling has
been reported to be mediated by phosphorylation of Tyr
845 and Tyr 1101 [45,46]. In this study we did not find
any changes either in Tyr 845 (EGFR tyrosine) or Tyr 416,
Src related tyrosine (which is an autophosphorylation site
on c-Src). Even though a role for Src in transphosphorylat-
ing EGFR tyrosine in the time course after a DE exposure
in-vivo cannot completely be ruled out, the present study
has not given any support for its involvement at the 6
hour post exposure sampling time.
IL-13 is a Th2 cytokine that has been implicated in allergy
and asthma airway inflammation, airway remodelling
and bronchial hyperresponsiveness. Increased bronchial
epithelial expression of IL-13 has previously been shown
after DE exposure in healthy non-atopic subjects [9]. This
response could potentially have been mediated by EGFR
downstream, such as via AP-1. Interestingly, IL-13 and
EGFR may interact in epithelial and goblet cell regulation.
IL-13 has been shown to activate neutrophils, and may by
interaction with EGFR, lead to increased goblet cell mucin
production and metaplasia [47,48]. The present findings
could therefore be of particular importance in asthmatic
and COPD subjects, who may experience exacerbations
after exposure to particulate matter air pollution [1,14].
Conclusion
The present investigation suggests that diesel exhaust
induced bronchial epithelial inflammatory responses are
mediated by the EGFR. The enhanced EGFR expression
and phosphorylation of the autophosphorylation sitePage 6 of 9
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ously demonstrated activation of the JNK, AP-1, p38
MAPK and NFkB pathways and their associated down-
stream signalling and cytokine production. We could not
identify any effect on the MEK and ERK pathways, suggest-
ing that at this 6 hour post exposure time point there was
no proliferative/differentiating signalling in the bronchial
epithelium. The involvement of EGFR in the airway
response to diesel exhaust could potentially be of even
more importance in subjects with asthma and COPD in
which this receptor tyrosine kinase has been indicated to




Fifteen non-atopic, non-smoking healthy subjects (11
males, 4 females) mean age; 24 years (range 21–28 years)
were included. All had normal lung function, negative
skin prick tests against common airborne allergens and
were free from respiratory tract infections for at least 6
weeks prior to or during the study period. Each subject
was exposed in a chamber to filtered air or DE for one
hour, on two separate occasions in a single blind rand-
omized sequence, at least 3 weeks apart, according to a
previously described standard protocol [10,49]. During
DE exposure, the concentration of particulates with a
mass median diameter of less than 10 µm (PM10) was kept
at 300 µg/m3. As a consequence associated pollutants
were at the following concentrations: NO2 1.6 ppm, NO
4.5 ppm, CO 7.5 ppm, total hydrocarbons 4.3 ppm, for-
maldehyde 0.26 mg/m3 and suspended particulates 4.3 ×
106 cm3. During exposure the subjects alternated rest and
moderate exercise (minute ventilation [VE] = 20 L/min/
m2) on a bicycle ergometer at 15-minute intervals. The
study was performed according to the Declaration of Hel-
sinki and was approved by the local ethics committee. All
subjects gave their written informed consent.
Bronchoscopy and processing of biopsies
Bronchoscopy with endobronchial biopsy sampling in
alternating lungs between the two occasions was per-
formed six hours after the end of the exposure period.
Biopsies were fixed in chilled acetone containing protease
inhibitors (20 mM iodoacetamide and 2 mM phenyl
methyl sulfonyl fluoride) and kept at -20°C overnight
(16–20 hours). The day after biopsy sampling, the biop-
sies were processed into glycolmethacrylate (GMA) resin,
as previously described [50]. The GMA embedded biop-
sies were stored in airtight containers at -20°C until used
for cutting and immunostaining with primary antibodies
given in table 2. From each subject and exposure, two sec-
tions from one biopsy with proper morphologic structure
were cut at 2 µm thickness. IgG and tris buffere saline with
0.5% triton-x-100 (TBST) with 1% BSA was used as nega-
tive controls (figure 1E). The endogenous peroxidase were
inhibited using 0.1% sodium azide and 0.3% hydrogen
peroxide in distilled water. After 3 × 5 minute washes in
0.1% TBST, non-specific antibody binding were blocked
with undiluted culture medium containing 10% fetal calf
serum and bovin serum albumin (BSA) followed by
another blocking step with rabbit norma serum or swine
normal serum for 30 minute each blocking step. Primary
antibody (Table 2) were applied and incubated overnight,
biotinylated rabbit anti mouse were used as secondary
antibody on slide stained with mAb, and biotinylated
swine anti rabbit antibody were applied on slides immu-
nostained with primary rabbit antibodies. Streptavidine-
biotin horseradish-peroxidase complex followed by
diaminobenzidine were used to visualize the immunorac-
tivity [15].
Quantification of immunostaining
The immunoreactivity was quantified using a colour
video camera (Sony DXC-950P 3-CCD three-chip power
HAD) containing 380 000 effective picture elements (pix-
els) (Sony, Tokyo Japan). The camera was connected to a
LEICA imaging workstation, with highly specific PC soft-
ware (Leica Q500IW, Leica Cambridge UK). Only areas
with intact epithelium were used for quantification. The
Table 2: Antibodies used for immunohistochemical staining
Antibody Clone or Source Dilution Specificity against Source
EGFR H11Mouse 1:140 EGFR Dako Glostrup, Denmark
P-Tyr 845 Rabbit 1:45 Phosphorylated Tyr 845on EGFR Cell Signaling Technology, MA, USA
P-Tyr 992 Rabbit 1:30 Phosphorylated Tyr 992on EGFR Cell Signaling Technology, MA, USA
P-Tyr 1068 1H12Mouse 1:45 Phosphorylated Tyr 1068on EGFR Cell Signaling Technology, MA, USA
P-Tyr 1110 Rabbit 1:30 Phosphorylated Tyr 1110on EGFR Santa Cruz Biotechnology, Santa Cruz, CA, USA
P-Tyr 1173 Rabbit 1:60 Phosphorylated Tyr 1173on EGFR Santa Cruz Biotechnology, Santa Cruz, CA, USA
P-Tyr 416 Rabbit 1:45 Phosphorylated Tyr 416on Src family Cell Signaling Technology, MA, USA
P-MEK 1, 2 Rabbit 1:40 Phosphorylated Ser 217/221 Cell Signaling Technology, MA, USA
P-ERK 1, 2 Rabbit 1:40 Phosphorylated Thr 202 and Tyr 204 of human 
ERK
Cell Signaling Technology, MA, USAPage 7 of 9
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(figure 1F), and given as percentage of the total epithelial
area selected with the image system, as previously
reported [15].
Statistical analysis
Subjects acted as their own controls, and the comparison
of post-air and post-DE stainings were performed with
Wilcoxon's paired rank test, using SPSS for Windows ver-
sion 11 (SPSS, Inc., Chicago, IL, USA). A p-value less than
0.05 was considered significant.
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